» Articles » PMID: 36157806

Diffusion Tensor Imaging Pipeline Measures of Cerebral White Matter Integrity: An Overview of Recent Advances and Prospects

Overview
Specialty General Medicine
Date 2022 Sep 26
PMID 36157806
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral small vessel disease (CSVD) is a leading cause of age-related microvascular cognitive decline, resulting in significant morbidity and decreased quality of life. Despite a progress on its key pathophysiological bases and general acceptance of key terms from neuroimaging findings as observed on the magnetic resonance imaging (MRI), key questions on CSVD remain elusive. Enhanced relationships and reliable lesion studies, such as white matter tractography using diffusion-based MRI (dMRI) are necessary in order to improve the assessment of white matter architecture and connectivity in CSVD. Diffusion tensor imaging (DTI) and tractography is an application of dMRI that provides data that can be used to non-invasively appraise the brain white matter connections fiber tracking and enable visualization of individual patient-specific white matter fiber tracts to reflect the extent of CSVD-associated white matter damage. However, due to a lack of standardization on various sets of software or image pipeline processing utilized in this technique that driven mostly from research setting, interpreting the findings remain contentious, especially to inform an improved diagnosis and/or prognosis of CSVD for routine clinical use. In this minireview, we highlight the advances in DTI pipeline processing and the prospect of this DTI metrics as potential imaging biomarker for CSVD, even for subclinical CSVD in at-risk individuals.

Citing Articles

Advanced magnetic resonance neuroimaging techniques: feasibility and applications in long or post-COVID-19 syndrome - a review.

Mohammadi S, Ghaderi S Ann Med Surg (Lond). 2024; 86(3):1584-1589.

PMID: 38463042 PMC: 10923379. DOI: 10.1097/MS9.0000000000001808.


The efficacy of preoperative diffusion tensor tractography on surgical planning and outcomes in patients with intramedullary spinal tumor.

Korkmazer B, Kemerdere R, Bas G, Arslan S, Demir B, Batkitar A Eur Spine J. 2023; 32(12):4321-4327.

PMID: 37530950 DOI: 10.1007/s00586-023-07872-5.

References
1.
Osman O, De Guio F, Chabriat H, Jouvent E . Why Are Only Some Subcortical Ischemic Lesions on Diffusion Magnetic Resonance Imaging Associated With Stroke Symptoms in Small Vessel Disease?. Stroke. 2018; 49(8):1920-1923. DOI: 10.1161/STROKEAHA.118.021342. View

2.
Heye A, Thrippleton M, Chappell F, Valdes Hernandez M, Armitage P, Makin S . Blood pressure and sodium: Association with MRI markers in cerebral small vessel disease. J Cereb Blood Flow Metab. 2015; 36(1):264-74. PMC: 4758556. DOI: 10.1038/jcbfm.2015.64. View

3.
Mak E, Dounavi M, Low A, Carter S, McKiernan E, Williams G . Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study. Neuroimage. 2021; 229:117749. DOI: 10.1016/j.neuroimage.2021.117749. View

4.
Brady L . Assessing biomarkers for brain diseases: progress and gaps. Genome Med. 2013; 5(3):23. PMC: 3706976. DOI: 10.1186/gm427. View

5.
Lambert C, Narean J, Benjamin P, Zeestraten E, Barrick T, Markus H . Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease. Neuroimage Clin. 2015; 9:194-205. PMC: 4564392. DOI: 10.1016/j.nicl.2015.07.002. View